SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015390
Filing Date
2021-11-10
Accepted
2021-11-10 07:27:49
Documents
68
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hook-20210930x10q.htm   iXBRL 10-Q 1678039
2 EX-31.1 hook-20210930xex31d1.htm EX-31.1 9859
3 EX-31.2 hook-20210930xex31d2.htm EX-31.2 9853
4 EX-32.1 hook-20210930xex32d1.htm EX-32.1 8345
5 GRAPHIC hook-20210930x10q002.jpg GRAPHIC 126422
  Complete submission text file 0001558370-21-015390.txt   6713233

Data Files

Seq Description Document Type Size
6 EX-101.SCH hook-20210930.xsd EX-101.SCH 50523
7 EX-101.CAL hook-20210930_cal.xml EX-101.CAL 50289
8 EX-101.DEF hook-20210930_def.xml EX-101.DEF 162882
9 EX-101.LAB hook-20210930_lab.xml EX-101.LAB 451868
10 EX-101.PRE hook-20210930_pre.xml EX-101.PRE 324824
11 EXTRACTED XBRL INSTANCE DOCUMENT hook-20210930x10q_htm.xml XML 1027614
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38869 | Film No.: 211394400
SIC: 2834 Pharmaceutical Preparations